Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 87
- 較 2023 年第 2 季 −1
- 總值
- $29.7 億
- 較 2023 年第 2 季 −$4.67 億 (−13.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| FOLDAmicus Therapeutics, Inc. | COM | 27,692,917 | $3.37 億 | 11.3% | +30,000+0.1% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 10,088,385 | $2.20 億 | 7.4% | 00.0% | 不變 | 歷史 |
| IMVTImmunovant, Inc. | COM | 3,814,691 | $1.46 億 | 4.9% | +1,290,908+51.1% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 3,965,978 | $1.42 億 | 4.8% | −50,419−1.3% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 2,463,451 | $1.13 億 | 3.8% | +268,630+12.2% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 3,074,542 | $9,073 萬 | 3.1% | +866,789+39.3% | 加碼 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 57,558,451 | $8,576 萬 | 2.9% | 00.0% | 不變 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 1,619,425 | $8,191 萬 | 2.8% | −321,250−16.6% | 減碼 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 4,256,104 | $7,810 萬 | 2.6% | +631,922+17.4% | 加碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 11,350,085 | $7,582 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 150,600 | $7,404 萬 | 2.5% | +81,600+118.3% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 1,342,751 | $6,845 萬 | 2.3% | −271,371−16.8% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 4,007,197 | $6,532 萬 | 2.2% | −389,919−8.9% | 減碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 4,043,191 | $6,028 萬 | 2.0% | +309,936+8.3% | 加碼 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 11,331,103 | $5,564 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 11,962,938 | $5,443 萬 | 1.8% | −2,073,472−14.8% | 減碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 12,757,562 | $4,988 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,688,873 | $4,923 萬 | 1.7% | −2,185,046−44.8% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 1,748,933 | $4,612 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| MDTMedtronic plc | Stock | 587,000 | $4,600 萬 | 1.5% | +120,000+25.7% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 3,819,456 | $4,461 萬 | 1.5% | +687,720+22.0% | 加碼 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 895,641 | $4,208 萬 | 1.4% | +152,803+20.6% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 3,491,500 | $4,043 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 1,827,901 | $3,893 萬 | 1.3% | +1,827,901 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,263,732 | $3,758 萬 | 1.3% | −683,205−35.1% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 1,321,795 | $3,659 萬 | 1.2% | +1,321,795 | 新進 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 1,520,416 | $3,515 萬 | 1.2% | −17,015−1.1% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 481,649 | $3,366 萬 | 1.1% | +210,156+77.4% | 加碼 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 996,306 | $3,265 萬 | 1.1% | +104,936+11.8% | 加碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,920,658 | $3,192 萬 | 1.1% | −367,835−16.1% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,517,467 | $3,109 萬 | 1.0% | +349,104+29.9% | 加碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 9,111,151 | $2,879 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ACRVAcrivon Therapeutics, Inc. | COMMON STOCK | 3,007,858 | $2,876 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 2,418,968 | $2,724 萬 | 0.9% | +2,418,968 | 新進 | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 6,984,319 | $2,500 萬 | 0.8% | −4,915,936−41.3% | 減碼 | 歷史 |
| TMCITreace Medical Concepts, Inc. | COM | 1,834,060 | $2,404 萬 | 0.8% | −383,190−17.3% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $2,304 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 2,309,470 | $2,252 萬 | 0.8% | −350,000−13.2% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 182,720 | $2,215 萬 | 0.7% | +101,646+125.4% | 加碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 672,042 | $2,124 萬 | 0.7% | +70,476+11.7% | 加碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 2,432,089 | $2,121 萬 | 0.7% | +379,221+18.5% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 617,500 | $2,109 萬 | 0.7% | −605,877−49.5% | 減碼 | 歷史 |
| VRCAVerrica Pharmaceuticals Inc. | COM | 5,038,983 | $1,958 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| BHVNBiohaven Ltd. | COM | 751,820 | $1,955 萬 | 0.7% | +431,000+134.3% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 124,637 | $1,820 萬 | 0.6% | −178,350−58.9% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 159,242 | $1,791 萬 | 0.6% | +59,192+59.2% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 1,054,273 | $1,759 萬 | 0.6% | −415,488−28.3% | 減碼 | 歷史 |
| RYZBRayzeBio, Inc. | COM | 776,805 | $1,725 萬 | 0.6% | +776,805 | 新進 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 1,132,491 | $1,724 萬 | 0.6% | −412,509−26.7% | 減碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,943,097 | $1,634 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 2,189,462 | $1,633 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,011,205 | $1,551 萬 | 0.5% | −765,181−43.1% | 減碼 | 歷史 |
| AORTArtivion, Inc. | COM | 931,352 | $1,412 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 277,683 | $1,363 萬 | 0.5% | −147,241−34.7% | 減碼 | 歷史 |
| EOLSEvolus, Inc. | COM | 1,485,801 | $1,358 萬 | 0.5% | +1,485,801 | 新進 | 歷史 |
| TCMDTactile Systems Technology Inc | COM | 707,159 | $993.6 萬 | 0.3% | +104,782+17.4% | 加碼 | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 716,441 | $985.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LONALeonaBio, Inc. | COM | 4,797,278 | $969.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NTRANatera, Inc. | COM | 218,178 | $965.4 萬 | 0.3% | −187,091−46.2% | 減碼 | 歷史 |
| ZYMEZymeworks Inc. | COM | 1,446,123 | $916.8 萬 | 0.3% | −970,109−40.1% | 減碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 3,495,933 | $881.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 380,828 | $873.0 萬 | 0.3% | +380,828 | 新進 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 3,823,557 | $810.6 萬 | 0.3% | +6,153+0.2% | 加碼 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 165,615 | $799.1 萬 | 0.3% | −19,000−10.3% | 減碼 | 歷史 |
| OMOutset Medical, Inc. | COM | 661,977 | $720.2 萬 | 0.2% | −240,383−26.6% | 減碼 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 2,751,395 | $715.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LABPLandos Biopharma, Inc. | COM NEW | 1,486,991 | $577.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,075,000 | $540.7 萬 | 0.2% | +1,075,000 | 新進 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 360,000 | $495.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 555,066 | $485.7 萬 | 0.2% | −504,734−47.6% | 減碼 | 歷史 |
| AXGNAxogen, Inc. | COM | 875,898 | $437.9 萬 | 0.1% | −588,924−40.2% | 減碼 | 歷史 |
| NVNOenVVeno Medical Corp | COMMON STOCK | 781,615 | $421.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 3,545,454 | $386.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SLGCSomaLogic, Inc. | CLASS A COM | 1,500,000 | $358.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 400,000 | $357.6 萬 | 0.1% | +309,252+340.8% | 加碼 | 歷史 |
| KRONKronos Bio, Inc. | COM | 1,752,745 | $227.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FBRXForte Biosciences, Inc. | COM | 3,265,359 | $216.2 萬 | 0.1% | +3,265,359 | 新進 | 歷史 |
| SLRNACELYRIN, Inc. | COM | 200,000 | $203.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 81,116 | $99.4 萬 | <0.1% | +81,116 | 新進 | 歷史 |
| VBIVVBI Vaccines Inc/BC | COM | 1,381,355 | $92.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM | 2,363,214 | $90.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| VERUVeru Inc. | COM | 1,089,878 | $78.4 萬 | <0.1% | +1,000,000+1,112.6% | 加碼 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM NEW | 44,971 | $6.21 萬 | <0.1% | −541,762−92.3% | 減碼 | 歷史 |
| MOTSMotus GI Holdings, Inc. | COM NEW | 90,027 | $4.05 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 60,000 | $1.13 萬 | <0.1% | 00.0% | 不變 | – |
| EQRx, Inc.26886C115 | *W EXP 12/17/202 | 250,000 | $1.00 萬 | <0.1% | 00.0% | 不變 | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 166,666 | $6,667 | <0.1% | 00.0% | 不變 | – |
選擇權（10 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| AKROAkero Therapeutics, Inc. | COM | – | $546.0 萬 |
| NVAXNovavax Inc | COM NEW | $377.3 萬 | – |
| SRPTSarepta Therapeutics, Inc. | COM | – | $313.0 萬 |
| PNTPOINT Biopharma Global Inc. | COM | $263.0 萬 | – |
| ARQTArcutis Biotherapeutics, Inc. | COM | $262.3 萬 | – |
| EYPTEyePoint, Inc. | COM NEW | $251.3 萬 | – |
| ETNB89bio, Inc. | COM | – | $162.0 萬 |
| ACRSAclaris Therapeutics, Inc. | COM | $145.0 萬 | – |
| VKTXViking Therapeutics, Inc. | COM | – | $24.0 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | $7.25 萬 | – |
2023 年第 2 季之後清倉（10 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 812,037 | $7,398 萬 | 2.1% | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 670,206 | $6,833 萬 | 2.0% | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 1,958,264 | $4,804 萬 | 1.4% | 歷史 |
| ILMNIllumina, Inc. | COM | 145,000 | $2,719 萬 | 0.8% | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 719,103 | $2,598 萬 | 0.8% | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 263,207 | $2,281 萬 | 0.7% | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 245,800 | $1,556 萬 | 0.5% | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 441,147 | $715.1 萬 | 0.2% | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 168,000 | $660.9 萬 | 0.2% | 歷史 |
| QTRXQuanterix Corp | COM | 130,000 | $293.1 萬 | 0.1% | 歷史 |